Where should you invest $100 right now?

Elon Musk just invented and patented this new AI technology…

And he's predicting it will launch a NEW industry that will grow more than 7 million percent in the coming years.

Even if he's only 10% right, that would still be enough to grow $100 into more than $700,000.

I Keep Them Young. I Can't Afford It Myself.
I'm 59 and my knees are going. My client is 74 and just took up tennis. Every morning I let myself into her house and help her stay decades ahead of me.
 
TRANSMISSION
From: Denise Whitaker, Tucson, Arizona
Date: October 2, 2045
Subject: The two clocks

Seven a.m. I let myself in.

Mrs. Alderman is already up. She's 74. This morning she did an hour on the rower, then asked me to move her tennis lesson to noon.

I'm 59. My knees sound like a gravel driveway.

I've looked after the Aldermans for eleven years. I cook, I clean, I drive. And once a month, I drive her up to the clinic on Skyline for her protocol.

That's what they call it. The protocol.

She sits in a chair for two hours while a machine rewinds her cells. Partial reprogramming, the brochure says. In other words… they turn the clock back inside her. Not a figure of speech. Her age markers read younger every single year.

It costs more than my house.

So I keep her young. Then I drive home to Ray, and my gravel knees, and the long slow ordinary business of getting old.

Here's the thing. I'm not bitter about it. Mostly.

Because my generation got the cheap miracles. And they were something.

Ray was headed for a bad heart at 50. Diabetes, the whole map of it. Then the weekly shot came along… pennies now, covered for everyone. He lost the weight. His numbers came home. He's still here, snoring beside me. I'll take it.

And his sister? Born with the blood disease that killed cousins on our mother's side, young. They fixed it. One treatment. When I was a girl that was a death sentence… now it's a Tuesday.

So I'm not ungrateful. The floor came up for all of us. We live longer, and healthier, than my parents ever dreamed.

But the ceiling ran away.

The Aldermans don't just get a few extra years now. They live on a different clock. Mrs. Alderman will likely see 110. Ray and I are hoping for good 80s.

Twenty years. That's the gap between the chair on Skyline and the rest of us.

I used to think everyone aged together. The whole street going gray at once. You could see it on the porches.

Not anymore.

I don't want her decades. I don't think I do. I just wonder what it does to a country when some folks get a second life… and some get one.

Anyway. She's calling. Tennis is back on.

I'll drive.

 
— Denise
Tucson, Arizona
Home-care aide, 34 years
Still on the one clock
 
◉ Snap back to the present
Denise's letter is fiction. The forces that build her world are not. Every signal in this transmission is already live… in July 2026.
BIOTECH
11% OF ADULTS
Denise's cheap miracle is already here. As of mid-2026, about 11% of American adults are taking a GLP-1 drug like Ozempic or Zepbound. Fifteen percent have tried one. Five years ago that number was a rounding error. This year Medicare began paying for them. A once-a-week shot is quietly changing the metabolic health of a whole country… the exact kind of floor-raiser Denise says she's grateful for.
Gallup — 2026
GENE THERAPY
$2.2 MILLION
Ray's sister got a one-and-done cure in the letter. In 2026 that cure has a name and a price. Casgevy, the CRISPR gene therapy for sickle cell disease, lists at $2.2 million per patient. On July 1, 2026, the FDA cleared it for children as young as two, making roughly 5,500 more kids eligible. One treatment. Maybe a lifetime fix. The medicine exists… the bill is the wall.
FDA; Vertex Pharmaceuticals — 2026
LONGEVITY
$3 BILLION
Mrs. Alderman's chair isn't made up from nothing. The idea is to partly reprogram cells to a younger state… turning the clock back without wiping the cell out. Altos Labs launched with $3 billion from backers including Jeff Bezos. Sam Altman's Retro Biosciences is chasing ten extra healthy years. And Life Biosciences, tied to Harvard's David Sinclair, now has FDA clearance for the first human test of reprogramming. It's early. It may not work. But it's on the calendar.
Scientific American; Longevity.Technology — 2025–2026
THE DIVIDE
14.6 YEARS
This is the part that keeps Denise up at night. Even before anyone rewinds a cell, money already buys years. Landmark work led by economist Raj Chetty found the richest 1% of American men live 14.6 years longer than the poorest 1%. For women, the gap is 10.1 years. That's the old divide… built on the plain plumbing we already have. Now hand the wealthy a second act nobody else can buy. The gap doesn't close. It splits into two clocks.
JAMA (Chetty et al.), 2016; American Medical Association
 
That's the transmission for today. Denise isn't real. The science is. One clock is splitting into two… and which one you're on is starting to depend on what you can pay. See you tomorrow.
2045
Letters from the transition · Est. 2026